Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

IGC Pharma (IGC) Inventory Average (2016 - 2025)

IGC Pharma has reported Inventory Average over the past 14 years, most recently at $1.0 million for Q3 2025.

  • Quarterly Inventory Average rose 28.57% to $1.0 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $1.0 million through Sep 2025, up 28.57% year-over-year, with the annual reading at $1.4 million for FY2025, 85.42% up from the prior year.
  • Inventory Average was $1.0 million for Q3 2025 at IGC Pharma, down from $1.4 million in the prior quarter.
  • Over five years, Inventory Average peaked at $5.3 million in Q1 2021 and troughed at $39500.0 in Q1 2023.
  • The 5-year median for Inventory Average is $1.5 million (2024), against an average of $2.1 million.
  • Year-over-year, Inventory Average plummeted 98.05% in 2023 and then skyrocketed 4286.08% in 2024.
  • A 5-year view of Inventory Average shows it stood at $3.0 million in 2021, then plummeted by 36.68% to $1.9 million in 2022, then plummeted by 49.01% to $970000.0 in 2023, then surged by 51.7% to $1.5 million in 2024, then tumbled by 31.8% to $1.0 million in 2025.
  • Per Business Quant, the three most recent readings for IGC's Inventory Average are $1.0 million (Q3 2025), $1.4 million (Q2 2025), and $1.4 million (Q1 2025).